KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Shares Outstanding: 2012-2024

Historic Shares Outstanding for Xenon Pharmaceuticals (XENE) over the last 12 years, with Dec 2024 value amounting to $76.4 million.

  • Xenon Pharmaceuticals' Shares Outstanding rose 1.75% to $77.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.1 million, marking a year-over-year increase of 1.75%. This contributed to the annual value of $76.4 million for FY2024, which is 1.39% up from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Shares Outstanding of $76.4 million as of FY2024, which was up 1.39% from $75.4 million recorded in FY2023.
  • Over the past 5 years, Xenon Pharmaceuticals' Shares Outstanding peaked at $76.4 million during FY2024, and registered a low of $35.0 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding was $75.4 million (2023), whereas its average is $71.5 million.
  • Data for Xenon Pharmaceuticals' Shares Outstanding shows a peak YoY soared of 47.48% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Xenon Pharmaceuticals' Shares Outstanding stood at $35.0 million in 2020, then spiked by 47.48% to $51.6 million in 2021, then climbed by 21.21% to $62.6 million in 2022, then rose by 20.42% to $75.4 million in 2023, then grew by 1.39% to $76.4 million in 2024.